Record Details

BMI and adipocytokine changes in COPD exacerbation and stable COPD

Online Publishing @ NISCAIR

View Archive Info
 
 
Field Value
 
Authentication Code dc
 
Title Statement BMI and adipocytokine changes in COPD exacerbation and stable COPD
 
Added Entry - Uncontrolled Name Cambay, Zafer
Ilhan, Nevin
Susam, Solmaz
Muz, Mehmet Hamdi
 
Uncontrolled Index Term Adiponectin; Chronic obstructive pulmonary disease (COPD); Interleukin-6; Malondialdehyde (MDA); Visfatin
 
Summary, etc. COPD is described by progressive airflow restriction and recurrent acute exacerbations, which is caused by inflammatory response occurring in lungs as a result of chronic inhalation of harmful particles and gases. The study was designed to determine the link of interleukin-6 (IL-6), adiponectin and visfatin with BMI and oxidant/antioxidant balance in Chronic Obstructive Pulmonary Disease (COPD), a systemic disease. The study comprised control (n=20), patients with COPD (n=37) from the Chest Diseases Clinic of Firat University Hospital. The serum MDA, IL-6, Visfatin and Adiponectin levels were evaluated by ELISA. Also, Pulmonary Function Tests were done. There was no significant difference between control and patients with COPD in terms of sex and age averages. On the contrary, BMI levels were statistically significantly lower in COPD group compared to the controls. MDA and adiponectin levels were higher, IL-6 and visfatin levels were lower in COPD groups contrary to controls. It was thought that the level changes of these parameters (MDA, IL-6, visfatin and adiponectin) may be an important factor in the development of COPD and in monitoring the treatment of COPD-related diseases.
 
Publication, Distribution, Etc. Indian Journal of Biochemistry and Biophysics (IJBB)
2021-10-05 14:14:55
 
Electronic Location and Access application/pdf
http://op.niscair.res.in/index.php/IJBB/article/view/25958
 
Data Source Entry Indian Journal of Biochemistry and Biophysics (IJBB); IJBB Vol. 58 (5) [October 2021]
 
Language Note en